Literature DB >> 16622982

Pancreatic neuroendocrine tumors: overview of recent advances and diagnosis.

Robert T Jensen1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16622982     DOI： 10.1016/j.gassur.2005.08.022

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  25 in total

Review 1.  Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.

Authors:  F Gibril; R T Jensen
Journal:  Dig Liver Dis       Date:  2004-02       Impact factor: 4.088

2.  Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.

Authors:  S U Goebel; C Heppner; A L Burns; S J Marx; A M Spiegel; Z Zhuang; I A Lubensky; F Gibril; R T Jensen; J Serrano
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

3.  Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?

Authors:  V D Corleto; B Annibale; F Gibril; S Angeletti; J Serrano; D J Venzon; G Delle Fave; R T Jensen
Journal:  Aliment Pharmacol Ther       Date:  2001-10       Impact factor: 8.171

4.  Zollinger-Ellison syndrome. Clinical presentation in 261 patients.

Authors:  P K Roy; D J Venzon; H Shojamanesh; A Abou-Saif; P Peghini; J L Doppman; F Gibril; R T Jensen
Journal:  Medicine (Baltimore)       Date:  2000-11       Impact factor: 1.889

Review 5.  Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.

Authors:  Fathia Gibril; Robert T Jensen
Journal:  Curr Gastroenterol Rep       Date:  2004-12

6.  Surgery to cure the Zollinger-Ellison syndrome.

Authors:  J A Norton; D L Fraker; H R Alexander; D J Venzon; J L Doppman; J Serrano; S U Goebel; P L Peghini; P K Roy; F Gibril; R T Jensen
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

Review 7.  Peptide receptor imaging and therapy.

Authors:  D Kwekkeboom; E P Krenning; M de Jong
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

8.  Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.

Authors:  Lucio Gullo; Marina Migliori; Massimo Falconi; Paolo Pederzoli; Rossella Bettini; Riccardo Casadei; Gianfranco Delle Fave; Vito D Corleto; Claudio Ceccarelli; Donatella Santini; Paola Tomassetti
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

9.  Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.

Authors:  Paolo L Peghini; Michiko Iwamoto; Mark Raffeld; Yuan-Jia Chen; Stephan U Goebel; Jose Serrano; Robert T Jensen
Journal:  Clin Cancer Res       Date:  2002-07       Impact factor: 12.531

Review 10.  Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.

Authors:  Fathia Gibril; Michael Schumann; Andrea Pace; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889
View more
  9 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.

Authors:  Satomi Kawamoto; Pamela T Johnson; Chanjuan Shi; Aatur D Singhi; Ralph H Hruban; Christopher L Wolfgang; Barish H Edil; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

3.  Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

Authors:  Parsia A Vagefi; Oswaldo Razo; Vikram Deshpande; Deborah J McGrath; Gregory Y Lauwers; Sarah P Thayer; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  Arch Surg       Date:  2007-04

4.  Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?

Authors:  Chanjuan Shi; Stanley S Siegelman; Satomi Kawamoto; Christopher L Wolfgang; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Radiology       Date:  2010-08-16       Impact factor: 11.105

5.  Management of malignant insulinoma.

Authors:  J C Ferrer-García; V Iranzo González-Cruz; S Navas-DeSolís; M Civera-Andrés; C Morillas-Ariño; A Merchante-Alfaro; C Caballero-Díaz; C Sánchez-Juan; C Camps Herrero
Journal:  Clin Transl Oncol       Date:  2013-03-05       Impact factor: 3.405

6.  Symptomatic hepatic metastasis of insulinoma 15 years after pancreatic resection.

Authors:  Samet Yardımcı; İlter Özer; Tahsin Dalgıç; Nesrin Turhan; Erdal Birol Bostancı
Journal:  Turk J Surg       Date:  2018-01-03

7.  Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.

Authors:  Sunita K Agarwal; Raja Jothi
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  Insulinoma and anaesthetic implications.

Authors:  Jyotsna Goswami; Pallavi Somkuwar; Yogesh Naik
Journal:  Indian J Anaesth       Date:  2012-03

9.  Insulinoma causing liver metastases 15 years after initial surgery, accompanied by glomerulonephritis.

Authors:  A Janez
Journal:  Case Rep Endocrinol       Date:  2012-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.